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The Significance of Aminopeptidases and Haematopoietic Cell Differentiation K. Razak, A. C. Newland S UMMA R Y. Aminopeptidases are a group of enzymes found on the cell surface and in the cytoplasmic compartments of many peripheral blood cell types and their progenitors. Their functional roles include the hydrolysis of several biologically active peptides and growth factors and some have proved to be of diagnostic and prognostic value in leukaemia. These enzymes may also be found in serum as a consequence of non-haematopoietic related diseases and so have been used as indicators of liver damage.
Haematopoietic cells in the bone marrow go through a process of growth and differentiation before being released into the peripheral circulation where they fulfill many functional roles. The enzyme activities of some aminopeptidases have been shown to modulate the growth of these cells. In addition, the activities of these enzymes themselves can be regulated by haematopoietic growth factors. However, the mechanisms that regulate their expression and activity are not fully understood. In this report the current literature has been reviewed for evidence of expression, regulation and clinical significance.
Aminopeptidases
are expressed by diverse cell types on the cell surface membrane or in the cytoplasmic compartment.
In the cytoplasm they may be present in granules or in microsomes. ' Haematopoietic cells in the bone marrow or in the peripheral blood express a number of different types of aminopeptidases that differ in their compartmentation, pH range of activity and their preferred substrate.' In the peripheral blood polymorphonuclear granulocytes, mononuclear lymphocytes, monocytes and platelets have all been shown to possess aminopeptidase activity.3-5 Cells that are in close proximity to these cells such as endothelial cells and fibroblasts may also express the same aminopeptidases.6,7
The functional roles of many of these enzymes are not clear but some have been implicated in the regulation of immune function by hydrolysing a K. Razak, A. C. Newland, Department of Haematology, The London Hospital Medical College, Whitechapel.
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Correspondence to: K. Razak. number of growth and activation factors or hormones. In this report the current literature is reviewed for evidence of function, regulation of expression and possible clinical value. Many aminopeptidases are poorly characterized and so this report concentrates on those enzymes that have been sufficiently characterized and are related to blood or blood related cells.
Cell Distribution of Aminopeptidases
Aminopeptidases are defined as enzymes that cleave amino groups near or at the N-or C-terminus of peptides. They include enzymes which hydrolyse the first peptide bond (aminoacyl-peptide hydrolases and iminoacyl-peptide hydrolases), and those which remove dipeptides from polypeptides (dipeptidylpeptide hydrolases).
Some peptidases act only on dipeptides or tripeptides which may also be considered as aminopeptidases (Table 1) . According to the method and conditions of analysis, several forms of aminopeptidase activity can be OF AMINOPEPTIDASES AND HAEMATOPOIETIC CELL DIFFERENTIATION in our laboratory we have found that by using flow cytometric techniques that these antibodies can be sub-classified on the basis of their ability to inhibit the binding of other competing CD13 antibodies (paper in preparation).
Further studies are required to establish the possible functional role of these different epitopes. Some are obviously related to enzyme activity but others may be framework epitopes, necessary for binding to other cell surface or substrate molecules for full functional activity to occur.
Peptidyl dipeptidase IV (CD26) found in lymphoid cells, has also been shown to have more than one epitope for antibody binding.29 Many aminopeptidases however have only been sufficiently characterized to establish a molecular weight and substrate specificity.34.3"
Clinical Significance
In the early 1960s alanine aminopeptidase activity was used as a specific marker for carcinoma of the head of the pancreas.
Hepatic and biliary tumours and drug induced hepatitis were found to also have elevated alanine aminopeptidase activities.36 In the serum aminopeptidase activities increase in childhood and decrease after puberty.
Their levels are also higher in men than in women and may be increased by smoking, alcohol consumption or drug intake.24 Leucine aminopeptidase is a liver cytosolic enzyme and can therefore be used as a marker of hepatic cell lysis. High activities of leucine aminopeptidase in serum is seen in patients with acute hepatitis from a variety of causes or following embolised hepatoma. In an attempt to further understand the movement of aminopeptidase-N during haematopoietic differentiation we performed experiments with the myeloid cell line HL60, often used as a model of cell differentiations3 and observed the CD13 expression during differentiation events when stimulated by the agent retinoic acid. We found that CD13 expression was lost by a large proportion of these cells (unpublished observations).
Our results collectively, support a model whereby immature myeloid haematopoietic cells express high levels of surface aminopeptidase but as these cells mature the expression is lost from the surface, but may be retained cytoplasmically, mature peripheral blood granulocytes and monocytes may then express this enzyme when the cell has been activated by an appropriate stimuli. Recent studies have shown that a cytosolic leucine aminopeptidase with a molecular weight of 53 kDa can be induced in fibroblastic cells by the immunoregulatory cytokine gamma-interferon.
The function of this enzyme is not known but it has been suggested that its activity may contribute to the direct antiviral effects of gamma-interferon by degrading viral proteins. This in turn may aid the processing and presentation of antigen via major histocompatibility complex (MHC) proteins to T-lymphocytes.34
Lymphocytes have also been shown to have various aminopeptidase activities in their cytosolic compartments and several recent publications have reported the identification of additional gamma-interferon inducible cytosolic proteases that like leucine aminopeptidase (53 kDa), may be involved in the processing of antigens for presentation on class I MHC molecules. The genes encoding some of these proteases are located within the MHC region. However, the largest of these proteases is approximately 30 kDa and none show the characteristic zinc binding motif of metalloproteases.'~1g~54~55
Oncogenes in Regulation of Aminopeptidases
The proto-oncogenes c-myc, c-myb, c-fos, c-fms and c-fes and their viral oncogene counterparts have been implicated in normal myelopoiesis and in myeloid leukaemia.56.57
The expression of these protooncogenes has been extensively analyzed upon chemically induced differentiation of myeloid leukaemic cells.58~5g However, the expression of only a few of these have been analyzed during in-vitro physiologically induced myelopoiesis of normal myeloid progenitor cells. 60,61 The c-fes oncogene is of particular interest because it encodes a P93 gene product with tyrosine kinase activity. The c-fes gene has also been mapped to chromosome 15, in close proximity to the gene encoding the CD1 3/Aminopeptidase-N molecule. Liebermann and Hoffman-Leibermann62 found that myeloid precursor enriched bone marrow cells express c-fes mRNA at low levels but this could be increased as an early event following stimulation of these cells by GM-CSF.
Evidence that this oncogene may play a functional role in cell differentiation is inferred from the work of Yu et al.63 They were able to transfect the c-fes gene into the K562 cell line. a highly undifferentiated cell of the erythroid/granulocytic lineage, and showed that these cells then acquire the ability to differentiate as well as respond to agents such as PMA, a phorbol ester. In our laboratories, inhibitors to tyrosine kinases induced higher than control levels of aminopeptidase-N enzyme activity (unpublished observations). These results imply that tyrosine phosphorylation of the aminopeptidase-N molecule may be a method of regulating enzyme activity and defects in a tyrosine kinase gene may therefore contribute to abnormal enzyme activity which in turn would alter the balance of regulatory factors in the bone marrow or peripheral blood that are substrates for these enzymes. Later it became clear that leucine could be hydrolysed by another aminopeptidase6' which furthermore hydrolysed alanylsubstrates even faster than leucine based ones. This broad substrate specificity has resulted in some confusion in terminology and characterisation.
Substrates of Aminopeptidases
There is now some agreement on the use of alanyl-Cnitroanilide as a substrate for determination of alanine aminopeptidase activity in serum and urine whilst alanylbeta-naphthylamide is used for histochemical analysis2
The removal of one or two amino acids from the N-terminal of polypeptides can result in the destabilisation of the substrate molecule by conformational change or permitting access of the substrate to further degradation by other enzymes. Recent studies have attempted to produce aminopeptidase resistant arg-gly-asp-peptide analogs that are stable in plasma. These would prove to be useful tools in antithrombotic studies involving the platelet associated molecules gpIIb/IITa.80 Collectively, these results suggest that aminopeptidases may be of importance in altering both the magnitude and quality of several cellular responses by mature and immature haematopoietic cells.
Inhibitors of Aminopeptidases

One of the most widly used inhibitors of aminopeptidases is a chemical called Bestatin (Ubenimex).8*-83
The use of this inhibitor has been used to study the effects of aminopeptidases on cell growth. Using bestatin. studies on T cell activation and growth have shown that peptidyl dipeptidase IV plays a key role in these cell processes. Moreover, the action of the cytokines IL-l, IL-2 and IL-6 was shown to be suppressed by this inhibitor.52
The growth of leukaemic and choriocarcinoma cell lines can also be inhibited.82 By contrast, bestatin has also been shown to significantly enhance the G-CSF and GM-CSF induced colony formation of human bone marrow cells. To explain these observations it has been suggested that the mechanisms of bestatin action in haematopoietic progenitor cells is by up regulation of the high affinity receptor for GM-CSF whilst in leukaemic cell lines suppression of amino acid incorporation via peptidase regulation occurs.83
The chemical modifying agents 2,3_butanedione, diazoacetamide and a soluble carbodiimide have recently been used to further characterize the active site of aminopeptidase-N.
These studies have suggested the presence of functional arginyl, histidyl, tyrosyl and aspartyl/glutamyl residues. Steady state kinetics have shown that the arginine, histidine and acidic residues are involved in substrate binding. whilst the tyrosine may play a role in the catalytic process.84
Conclusions
Aminopeptidases are found to be expressed on all types of haematopoetic cells. These enzymes have however been difficult to characterize as many have overlapping substrate specificity. As a result there has been some confusion in the literature as to the terminology used to describe the enzyme under investigation. For example, there are many papers that confuse leucine aminopeptidase (EC 3.4.11.1) activity with that of alanine aminopeptidase activity (EC 3.4.11.2). As can be seen from Table 2 a number of  aminopeptidases are also able to cleave the same naturally occuring activation and growth factors. The in vivo biological effects of the hydrolysis of these factors at different sites on the molecule is however not yet clear. It would seem likely that several aminopeptidases may be required to complete some physiological cascades. The majority of work has however concentrated on enzymes that have been shown to have homology with differentiation related antigens such as CD1 3, CD10 and CD26. More work is required not only 
